Michael Paul Dunn JR bought $347M of SOPAQ
director at SOCIETY PASS INCORPORATED.. 12,000 shares at an average of $28,920.00, traded Feb 3, 2025, filed Feb 4, 2025.
Score components
- +15RoleDirector
- +25Trade size$347.0M at market
- +10Relative to holdingsHoldings up 4580%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -43.9%, 3m -44.3%, 6m -43.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-010132, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 3, 2025 | SOpen-market sale Common Stock | -10,714 | $29,356.36 | $315M | 262 | Feb 4, 2025 |
| Feb 3, 2025 | POpen-market purchase Common Stock | +12,000 | $28,920.00 | $347M | 12,262 | Feb 4, 2025 |
Related signals
Other insiders at SOCIETY PASS INCORPORATED. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | SOPAQsell SOCIETY PASS INCORPORATED. | Michael Paul Dunn JR director | $315M 10,714 shares | -98% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.